Format

Send to

Choose Destination
  • The following terms were not found in PubMed: NCI%2C, NHLBI%2FPBMTC, Transplantation%3A.
See comment in PubMed Commons below
Biol Blood Marrow Transplant. 2012 Jan;18(1):6-15. doi: 10.1016/j.bbmt.2011.11.014. Epub 2011 Nov 17.

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Author information

1
Perelman School of Medicine, University of Pennsylvania, Philadelphia, 19104, USA. buninn@email.chop.edu

Abstract

Defective immune reconstitution is a major barrier to successful hematopoietic cell transplantation (HCT), and has important implications in the pediatric population. There are many factors that affect immune recovery, including stem cell source and graft-versus-host disease (GVHD). Complete assessment of immune recovery, including T and B lymphocyte evaluation, innate immunity, and response to neoantigens, may provide insight as to infection risk and optimal time for immunizations. The increasing use of cord blood grafts requires additional study regarding early reconstitution and impact upon survival. Immunization schedules may require modification based upon stem cell source and immune reconstitution, and this is of particular importance as many children have been incompletely immunized, or not at all, before school entry. Additional studies are needed in children post-HCT to evaluate the impact of differing stem cell sources upon immune reconstitution, infectious risks, and immunization responses.

PMID:
22100979
PMCID:
PMC3253930
DOI:
10.1016/j.bbmt.2011.11.014
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center